Source MDx And Brigham And Women’s Hospital Partner To Study RNA-Based Biomarkers For Multiple Sclerosis

Source MDx today announced a partnership with Brigham and Women’s Hospital in Boston to examine RNA-based biomarkers in multiple sclerosis (MS) patients and healthy control participants unaffected by the disease. The goal of the study is to identify diagnostic markers and to determine markers of active disease (relapses) or stable disease, along with response markers for currently available MS therapies.

More: continued here

Filed under: Multiple Sclerosis on November 7th, 2008